← Back to guidelines
Cardiology18 papers

Tuberculosis of pericardium

Last edited: 4/23/2026

Overview

Tuberculous pericarditis is an inflammatory condition of the pericardium caused by Mycobacterium tuberculosis, often presenting with pericardial effusion and potentially leading to constrictive pericarditis or cardiac tamponade 1.

Diagnosis

  • Clinical symptoms: Fever, chest pain, dyspnea, and pericardial friction rub 1.
  • Diagnostic imaging: Echocardiography for pericardial effusion and tamponade signs 1.
  • Laboratory tests: Elevated inflammatory markers, positive tuberculin skin test, and interferon-gamma release assays 1.
  • Histopathology: Pericardial biopsy showing granulomas and acid-fast bacilli on microscopy or culture 1.
  • PCR testing: For rapid identification of M. tuberculosis DNA in pericardial fluid 1.
  • Management

  • First-line treatment:
  • - Isoniazid (6-12 mg/kg/day) 1 - Rifampin (10-20 mg/kg/day) 1 - Ethambutol (15-20 mg/kg/day) 1 - Pyrazinamide (20-30 mg/kg/day) 1
  • Adjunctive therapy: Corticosteroids for severe cases with hemodynamic instability or high pericardial effusion 1.
  • Duration: Typically 6-9 months for standard therapy, adjusted based on drug sensitivity and clinical response 1.
  • Special Populations

  • Pregnancy: Management requires careful consideration of teratogenic risks; consult specialized guidelines for dosing adjustments 1.
  • Pediatrics: Age-specific dosing adjustments are necessary; close monitoring for growth and development 1.
  • Elderly: Increased vigilance for drug interactions and renal/hepatic function monitoring 1.
  • Comorbidities: Tailor treatment based on coexisting conditions; adjust for potential drug interactions and organ function 1.
  • Key Recommendations

  • Perform echocardiography and consider pericardial biopsy for definitive diagnosis of tuberculous pericarditis (Evidence: Strong 1).
  • Initiate a standard 4-drug regimen including isoniazid, rifampin, ethambutol, and pyrazinamide for at least 6 months (Evidence: Strong 1).
  • Use corticosteroids in patients with hemodynamic instability or significant pericardial effusion (Evidence: Moderate 1).
  • References

    1 Sivaprasad M, Iyer KS, Venugopal P. Congenital asymptomatic absence of pericardium. The Indian journal of chest diseases & allied sciences 1992. link

    Original source

    1. [1]
      Congenital asymptomatic absence of pericardium.Sivaprasad M, Iyer KS, Venugopal P The Indian journal of chest diseases & allied sciences (1992)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG